[1]Salati;Stathis[DrugsoftheFuture,2014,vol.39,#10,p.677-684]
[1]Salati;Stathis[DrugsoftheFuture,2014,vol.39,#10,p.677-684]
[1]Salati;Stathis[DrugsoftheFuture,2014,vol.39,#10,p.677-684]
[1]DrugsoftheFuture,2014,vol.39,p.677-684
[1]Salati;Stathis[DrugsoftheFuture,2014,vol.39,#10,p.677-684]
[2]Salati;Stathis[DrugsoftheFuture,2014,vol.39,#10,p.677-684]
Title: Pan S, et al. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. ACS Med Chem Lett. 2010 Mar 16;1(3):130-4.
Title: Irvine DA, et al. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep. 2016 May 9;6:25476.